Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

Bibliographic Details
Title: Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Authors: Emiel A. De Jaeghere, Sandra Tuyaerts, An M. T. Van Nufel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, Sandrine Aspeslagh, Alex De Caluwé, Eline Naert, Diether Lambrechts, An Hendrix, Olivier De Wever, Koen K. Van de Vijver, Frédéric Amant, Katrien Vandecasteele, Hannelore G. Denys
Source: Cancer Immunology, Immunotherapy, Vol 74, Iss 1, Pp 1-4 (2024)
Publisher Information: Springer, 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1432-0851
Relation: https://doaj.org/toc/1432-0851
DOI: 10.1007/s00262-024-03873-5
Access URL: https://doaj.org/article/7a2dbda2ca4c4bf0a6184c73b5f2570b
Accession Number: edsdoj.7a2dbda2ca4c4bf0a6184c73b5f2570b
Database: Directory of Open Access Journals
More Details
ISSN:14320851
DOI:10.1007/s00262-024-03873-5
Published in:Cancer Immunology, Immunotherapy
Language:English